Tonix Pharmaceuticals Holding (TNXP) PEG Ratio

Price: $15.03
Market Cap: $103.37M
Avg Volume: 1.72M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.514
52W Range: $6.76-672
Website: Tonix Pharmaceuticals Holding

PEG Ratio Summary

  • Tonix Pharmaceuticals Holding's trailing twelve month (TTM) PEG ratio is 0.00.
  • Tonix Pharmaceuticals Holding's annual PEG ratio as of today is 0.01.
  • Tonix Pharmaceuticals Holding's quarterly PEG ratio is 0.00.

What is the PEG Ratio?

The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.

How is the PEG Ratio calculated?

The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:

PEG Ratio = (P/E Ratio) / (EPS Growth Rate)

This helps investors to determine a stock's value while considering the company's earnings growth.

Related Metrics

Other important metrics to assess Tonix Pharmaceuticals Holding's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: -0.19
    • Quarterly: -0.01
    • TTM: 0.00
  • P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
    • Annual: 2.41
    • Quarterly: 0.29
    • TTM: 10.24
  • P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
    • Annual: 0.17
    • Quarterly: 0.01
    • TTM: 0.00
  • P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: -0.40
    • Quarterly: -0.05
    • TTM: -0.01

These metrics provide insights into Tonix Pharmaceuticals Holding's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

TTM PEG Ratio

0.00

Annual PEG Ratio

0.01

Quarterly PEG Ratio

0.00

Tonix Pharmaceuticals Holding Historical PEG Ratio

Historical P/E Ratio

Historical P/S Ratio

Historical P/B Ratio

Historical P/CF Ratio

Tonix Pharmaceuticals Holding Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year PEG Ratio P/E Ratio P/S Ratio P/B Ratio P/CF Ratio
2024 0.01 -0.19 2.41 0.17 -0.40
2023 0.09 -5.89 88.40 6.51 -6.73
2022 0.20 -12.18 0.00 6.87 -14.51
2021 2.61 -141.24 0.00 59.60 -172.51
2020 0.00 -122.38 0.00 72.85 -131.47
2019 0.00 0.00 0.00 0.00 0.00
2018 0.00 0.00 0.00 0.00 0.00
2017 0.00 0.00 0.00 0.00 0.00
2016 0.00 0.00 0.00 0.00 0.00
2015 0.00 0.00 0.00 0.00 0.00
2014 0.00 0.00 0.00 0.00 0.00
2013 0.00 0.00 0.00 0.00 0.00
2012 0.00 0.00 0.00 0.00 0.00
2011 -0.60 -1890.24 0.00 -2673.01 -2486.92
2010 1448.66 -61680.43 0.00 -192435.13 -60795.46

Related Metrics

Explore detailed financial metrics and analysis for TNXP.